Morgan Stanley reiterates Rivian stock Underweight on robotaxi deal

Uber will invest up to $1.25 billion in Rivian and commit to deploying 50,000 fully autonomous R2 robotaxis (initial ~10,000 in 2028, option for up to 40,000 from 2030), representing a material strategic and capital infusion. Rivian priced the R2 Performance at $57,990 with deliveries expected spring 2026; revenue is forecast to grow ~33% in fiscal 2026, though gross margins are still slim at 2.67% and the company has a current ratio of 2.33. Analysts are split: Morgan Stanley reiterated an Underweight with a $12 price target (stock trading at $15.68), while Stifel and Benchmark hold Buy targets of $20 and $25, respectively, leaving near-term valuation and profitability questions despite the positive autonomy partnership.

Analysis

The Uber distribution pathway materially shortens commercial validation time for a purpose-built robotaxi platform, but scale economics remain a function of utilization, downtime, and operating margins on fleet services rather than vehicle ASP alone. Expect the first 3–5 years to be defined by per-unit learning curves (software reliability, remote ops, maintenance cadence) that will drive step-changes in unit economics only after a multi-thousand vehicle installed base.

Second-order winners are modular sensor and edge-compute suppliers that can standardize across fleets — their revenue is sticky and scales with vehicle uptime; conversely, OEMs that treat autonomy as a one-off feature risk margin pressure as fleet buyers demand integrated, serviceable platforms. Supply-chain bottlenecks for high-end LiDAR, custom silicon packaging, and thermal management could become gating constraints; production cadence will likely be gated by these subsystems long after battery cell availability normalizes.

Primary risks are operational (safety incidents, regulatory delays) and capital structure (conditional capital infusions tied to milestones), creating cliff events at milestone dates and regulatory checkpoints over the next 12–36 months. Reversals are most likely if early fleet telemetry shows utilization <40–50% of modelled assumptions or if insurance/third-party repair costs run materially above internal estimates, both of which would push payback curves out by multiple years.

The consensus narrative treats distribution as de-risking; it underweights the variable opex of running dense urban fleets and overweights headline capital commitments relative to milestone execution. If you believe tech execution is binary, the current partnership should be valued as a step-function option — large upside if autonomy clears regulatory/operational hurdles, steep downside if fleet economics fall short or capital markets tighten again.

Key Decisions for Investors

• Long selective autonomy suppliers (e.g., LAZR) 12–24 months — allocate 3–5% position size: these names gain recurring revenue per vehicle. Stop 30% from entry; target 2.5x return if early fleet wins are announced.
• Paired options: Buy RIVN 12–18 month call spread (buy 30/45, sell 45/60) sized to 2% portfolio — asymmetric upside if execution de-risks without full equity dilution. Max loss = premium (~100% of spend); target 3x if milestone-driven orders convert.
• Relative value: Long UBER (1–2 year horizon) / Short legacy OEM exposure (e.g., names with heavy ICE footprints) equal notional — plays service-led margin capture across mobility platforms. Risk: mobility demand shock; haircut positions by 25% on quarterly active-user weakness.
• Event hedge: Buy 6–12 month puts on high-beta EV names (including RIVN) sized to cover equity exposure around key milestone dates — protects against binary regulatory/telemetry shocks. Keep cost <0.5% portfolio by using out-of-the-money strikes to limit drag.